India to United States: Irbesartan Export Trade Route

The India to United States Irbesartan corridor is one of India's established pharmaceutical export routes, with 196 shipments documented worth a combined $37.1M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's irbesartan manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $189.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 13.5%, placing it at rank #10 among India's top irbesartan export destinations globally.

On the import side, key buyers of Indian irbesartan in United States include MACLEODS PHARMA USA,INC, MACLEODS PHARMA USA,INC,, MACLEODS PHARMA USA INC and 13 others. MACLEODS PHARMA USA,INC is the single largest importer with 8 shipments valued at $19.8M USD.

India's irbesartan exports to United States are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 63 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, HETERO LABS LIMITED — together account for 96% of total trade value on this route. The average shipment value of $189.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as drugs and pharmaceuticals harmless medicines irbesartan and hydrochlorothiazidetablets usp (300 mg/12.5 mg) and irbesartan tablets usp 75mg 1x90s (13197 pac), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MACLEODS PHARMA USA,INC is the largest importer with 8 shipments worth $19.8M USD — representing 53% of all irbesartan imports from India on this route. A total of 16 buyers are active on this corridor.